Delivery Order 36F79723D0171-36C24626N0637
Award Date 4/10/26
Potential Completion Date 4/24/26
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $26,086.86 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Takeda will provide emergency pharmaceutical products to Veterans Integrated Service Network 20 in support of the VA-VHA's healthcare programs. Performance will occur in Cambridge, Massachusetts through June 2024. As the prime contractor, Takeda will leverage its parent company Takeda...
- This federal contract award to Tri-Pharma, Inc. (doing business as Tri-Pharma Inc.) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The $123,374.00 firm-fixed-price purchase order, which has no set-aside designation, is for IV solutions. The contract supports the Hurricane Harvey 2017 National Interest Action. Tri-Pharma is a minority-owned, self-certified small disadvantaged business that specializes in sourcing and...
- The U.S. Department of Veterans Affairs (VA) awarded a $27,913.44 firm-fixed price delivery order contract to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide emergency pharmaceutical orders. The contract is a delivery order under Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. The contract supports the VA's Veterans Health Administration in delivering specialty...
- Takeda Pharmaceuticals America Inc. received a delivery order valued at $28,111.59 from Veterans Integrated Service Network 12 for MARIBAVIR (LIVTENCITY), an antiviral pharmaceutical for transplant-related infections. This firm fixed-price delivery order, awarded on February 4, 2026, with an ultimate completion date of April 3, 2026, represents a child contract under the General Services Administration Pharmaceuticals and Drugs Schedule (FSS-61-IB). The award was not designated with a...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the provision of medication. The contract has a ceiling value of $103,600.00 and is set aside for total small business participation. Tri-Pharma, Inc. is a supplier of pharmaceuticals, personal protective equipment (PPE), and medical supplies to various federal government agencies, including the VA, Department of Health and Human...
- This delivery order from the Department of Veterans Affairs Veterans Health Administration awards Takeda Pharmaceuticals America, Inc. $36,808.10 to supply emergency ponatinib 45 mg tablets. Takeda Pharmaceuticals America, a foreign-owned manufacturer, will deliver the products under a firm fixed price contract by September 30, 2022. The award draws from Takeda's multiple award Federal Supply Schedule contract for Pharmaceuticals and Drugs, which has no set-aside designation. Takeda currently...
- The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order for TAKHZYRO 150MG/ML syringes. Takeda Pharmaceuticals America Inc. will deliver the syringes to a location in Lexington, Massachusetts by September 21, 2023 to fulfill requirements under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), the parent vehicle held by Takeda Pharmaceutical Company LIMITED. The funding...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $10,888.08, is for the supply of the pharmaceutical drug FILSPARI 200 MG. The contract was awarded through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), and is a firm fixed-price delivery order with a completion date of June 11, 2025. Travere...
- This is a firm fixed-price delivery order under Takeda Pharmaceuticals America Inc.'s General Services Administration (GSA) Pharmaceuticals and Drugs Schedule contract. The order, valued at $40,407.82, is for the emergency procurement of LIVTENCITY medication to treat kidney transplant infections. The contract was awarded on February 28, 2022, by the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs (VA), and has an ultimate completion...
- The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The order calls for Emergent Devices to supply pharmaceutical items to meet the clinical needs of VA's Veterans Integrated Service Network 12, located in Wayne, Pennsylvania, with performance from December 4-11, 2020. No subcontractors or set aside designations were identified. This order...